Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
121477982 | 12147798 | 2 | F | 20160830 | 20160304 | 20160909 | EXP | JP-PFIZER INC-2016132858 | PFIZER | SUGIMOTO, N.. A PHASE II TRIAL OF TRASTUZUMAB COMBINED WITH IRINOTECAN IN PATIENTS WITH ADVANCED HER2-POSITIVE CHEMO-REFRACTORY GASTRIC CANCER: OGSG1203 (HERBIS-5). JOURNAL OF CLINICAL ONCOLOGY. 2016;34 | 0.00 | Y | 0.00000 | 20160909 | OT | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
121477982 | 12147798 | 1 | PS | IRINOTECAN HCL | IRINOTECAN HYDROCHLORIDE | 1 | Intravenous drip | 150 MG/M2, EVERY 2 WEEKS | 20571 | 150 | MG/M**2 | ||||||||
121477982 | 12147798 | 2 | SS | TRASTUZUMAB | TRASTUZUMAB | 1 | Intravenous drip | 8 MG/KG, ON DAY 1 OF THE FIRST CYCLE | 0 | 8 | MG/KG | ||||||||
121477982 | 12147798 | 3 | SS | TRASTUZUMAB | TRASTUZUMAB | 1 | Intravenous drip | 6 MG/KG, EVERY 3 WEEKS | 0 | 6 | MG/KG | Q3W |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
121477982 | 12147798 | 1 | HER-2 positive gastric cancer |
121477982 | 12147798 | 2 | HER-2 positive gastric cancer |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
121477982 | 12147798 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
121477982 | 12147798 | Death |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |